Pharmacokinetic Study to Determine Time to Steady-State of an Oral Testosterone Undecanoate Formulation in Hypogonadal Men.
Phase of Trial: Phase II
Latest Information Update: 18 Aug 2010
At a glance
- Drugs Testosterone undecanoate (Primary)
- Indications Hypogonadism
- Focus Pharmacokinetics
- 18 Aug 2010 Actual end date added to 1 Jan 2010 as reported by ClinicalTrials.gov.
- 18 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Sep 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov